Genetic testing and first presymptomatic diagnosis in Moroccan families at high risk for breast/ovarian cancer

Oncology Letters

Volumn 2, Issue 2, 2011, Pages 389-393

  Laarabi, Fatima Zahra ^a,b   Jaouad, Imane Cherkaoui ^a,b   Ouldim, Karim ^b   Aboussair, Nisrine ^b   Jalil, Abdelouahed ^c   Gueddari, Brahim El Khalil El ^d   Benjaafar, Noureddine ^d   Sefiani, Abdelaziz ^a,b  

^a MOHAMMED V UNIVERSITY   (Morocco)

^b Institut National d'Hygiène   (Morocco)

^c Service de Chirurgie B   (Morocco)

^d NATIONAL INSTITUTE OF ONCOLOGY   (Morocco)

Author keywords

BRCA1 2 genes; Hereditary breast ovarian cancer; Presymptomatic DNA testing

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; EARLY DIAGNOSIS; FAMILIAL CANCER; FEMALE; FOUNDER EFFECT; GENE MUTATION; GENETIC ANALYSIS; HIGH RISK PATIENT; HUMAN; MOROCCO; OVARY CANCER; PATIENT MONITORING;

EID: 79551619160     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.248     Document Type: Article

References (18)

1. ACOG Committee on Practice Bulletins: Hereditary breast and ovarian cancer syndrome. Gynecol Oncol 113: 6-11, 2009.
2. Robson ME, Boyd J, Borgen PI and Cody HS III: Hereditary breast cancer. Curr Probl Surg 38: 387-480, 2001.
3. Risch HA, McLaughlin JR, Cole DE, et al: Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98: 1694-1706, 2006.
4. Rubin SC, Blackwood MA, Bandera C, et al: BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. Am J Obstet Gynecol 178: 670-677, 1998.
5. Ratajska M, Brozek I, Senkus-Konefka E, Jassem J, Stepnowska M, Palomba G, Pisano M, Casula M, Palmieri G, Borg A and Limon J: BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. Oncol Rep 19: 263-268, 2008.
6. Mohamad HB: Counseling for male BRCA mutation carriers: a review. Apffelstaedt JP Breast 17: 441-450, 2008.
7. Filippini S, Blanco A, Fernández-Marmiesse A, Alvarez- Iglesias V, Ruíz-Ponte C, Carracedo A and Vega A: Multiplex SNaPshot for detection of BRCA1/2 common mutations in Spanish and Spanish related breast/ovarian cancer families. BMC Med Genet 29: 40, 2007.
8. Whittemore AS, Gong G and Itnyre J: Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based casecontrol studies of ovarian cancer. Am J Hum Genet 60: 496-504, 1997.
9. Hanson H and Hodgson S: Cancer genetics and reproduction, best practice and research. Clin Obstet Gynaecol 24: 3-18, 2010.
10. Neuhausen SL: Ethnic differences in cancer risk resulting from genetic variation. Cancer 86: 2575-2582, 1999.
11. Ferla R, Calo V, Cascio S, Rinaldi G, Badalamenti G, Carreca I, Surmacz E, Colucci G, Bazan V and Russo A: Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18: 93-98, 2007.
12. Roa BB, Boyd AA, Volcik K, et al: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14: 185-187, 1996.
13. Neuhausen S, Gilewski T, Norton L, et al: Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13: 126-128, 1996.
14. Uhrhammer N, Abdelouahab A, Lafarge L, Feillel V, Ben Dib A and Bignon YJ: BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases. int J Med Sci 5: 197-202, 2008.
15. Antoniou A, Pharoah PD, Narod S, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117-1130, 2003.
16. King MC, Marks JH and Mandell JB: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. New York Breast Cancer Study Group. Science 302: 643-646, 2003.
17. Loman N, Bladstrom A, Johannsson O, Borg A and Osson H: Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res 5: 175-186, 2003.
18. Waters CM, Hoover AC, McClain LC, Moore TT, Rogers CT and Thornton K: Current guidelines and best practice evidence for intensified/enhanced breast cancer screening in women with BRCA mutations. J Nurs Pract 5: 447-453, 2009.